Animal testing is crucial to the development of new antifungal compounds. T
his review describes the role that murine and other animal models have play
ed in the development of three classes of antifungal agents: the polyenes,
the triazoles and the echinocandins and the ways in which these models have
been either the positive link in the path from in vitro studies to the pat
ient, or have foreclosed later clinical evaluation. Efficacy studies in par
ticular mycoses are discussed, as well as studies designed to determine whe
ther combinations of antifungal drugs may have value over single agents. (C
) 2000 Harcourt Publishers Ltd.